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The vasopressin-regulated water channel aquaporin-2 (AQP2) is known to tetramerize in the apical membrane of
the renal tubular cells and contributes to urine concentration. We identified three novel mutations, each in a single
allele of exon 4 of the AQP2 gene, in three families showing autosomal dominant nephrogenic diabetes insipidus
(NDI). These mutations were found in the C-terminus of AQP2: a deletion of G at nucleotide 721 (721 delG), a
deletion of 10 nucleotides starting at nucleotide 763 (763–772del), and a deletion of 7 nucleotides starting at
nucleotide 812 (812–818del). The wild-type AQP2 is predicted to be a 271–amino acid protein, whereas these
mutant genes are predicted to encode proteins that are 330–333 amino acids in length, because of the frameshift
mutations. Interestingly, these three mutant AQP2s shared the same C-terminal tail of 61 amino acids. In Xenopus
oocytes injected with mutant AQP2 cRNAs, the osmotic water permeability (Pf) was much smaller than that of
oocytes with the AQP2 wild-type (14%–17%). Immunoblot analysis of the lysates of the oocytes expressing the
mutant AQP2s detected a band at 34 kD, whereas the immunoblot of the plasma-membrane fractions of the oocytes
and immunocytochemistry failed to show a significant surface expression, suggesting a defect in trafficking of these
mutant proteins. Furthermore, coinjection of wild-type cRNAs with mutant cRNAs markedly decreased the oocyte
Pf in parallel with the surface expression of the wild-type AQP2. Immunoprecipitation with antibodies against
wild-type and mutant AQP2 indicated the formation of mixed oligomers composed of wild-type and mutant AQP2
monomers. Our results suggest that the trafficking of mutant AQP2 is impaired because of elongation of the C-
terminal tail, and the dominant-negative effect is attributed to oligomerization of the wild-type and mutant AQP2s.
Segregation of the mutations in the C-terminus of AQP2 with dominant-type NDI underlies the importance of this
domain in the intracellular trafficking of AQP2.
Introduction
Water movement across the cell membrane is a funda-
mental process in the maintenance of intracellular ho-
meostasis. Water molecules move through a pore of a
water channel, which has now been designated as “aqua-
porin” (AQP). After the discovery of AQP1 (MIM
107776) in 1992, AQPs have been detected in many
organisms, including bacteria, yeast, plants, and animals
(Park and Saier 1996; Ishibashi and Sasaki 1998). A
cDNA for AQP2 (MIM 107777) (Fushimi et al. 1993),
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a vasopressin-regulated water channel, was isolated in
1993. AQP2 is localized predominantly at the subapical
region of the principal cells of the collecting tubule and
the inner medullary collecting duct cells (Marples et al.
1995; Nielsen et al. 1995a; Yamamoto et al. 1995). In
response to binding of vasopressin to the V2 receptor
at the basolateral membrane, cAMP-dependent pro-
cesses are activated, leading to an increase in the osmotic
water permeability of the apical membrane by triggering
exocytosis of AQP2-containing vesicles to the apical
membrane (Marples et al. 1995; Nielsen et al. 1995a;
Yamamoto et al. 1995).
Congenital nephrogenic diabetes insipidus (NDI) is a
hereditary disease characterized by a lack of respon-
siveness to arginine vasopressin (AVP) in the renal col-
lecting tubule. The clinical manifestations are polyuria
and polydipsia. In the majority of patients with inher-
ited NDI, the mode of inheritance is X-linked recessive
(NDI, X-linked [MIM 304800]). The mutations that are
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Figure 1 Pedigrees of the three families with NDI. Squares and circles represent males and females, respectively.
responsible were found in the V2 receptor gene, located
in the Xq28 chromosomal region (Pan et al. 1992);
subsequently, 1150 mutations have been reported (Ar-
thus et al. 2000). Less frequently, patients with NDI
show an autosomal recessive form (NDI, autosomal re-
cessive [MIM 222000]). After isolation of the cDNA
for human AQP2 (Sasaki et al. 1994), mutations were
identified in the AQP2 gene in patients with this form
of NDI (Deen et al. 1994). Presently, 30 AQP2 muta-
tions are known (Morello and Bichet 2001; D.G.B.,
unpublished data). More recently, in 1998, an autoso-
mal dominant form of NDI was reported (Mulders et
al. 1998), in which a mutation in one allele of theAQP2
gene caused an E258K substitution (NDI, autosomal
dominant [MIM 125800]). In the present study, we re-
port three cases of autosomal dominant NDI. Three
different novel AQP2 mutations were identified, which
are predicted to result in elongation of the C-terminal
tail of AQP2. To our knowledge, this is the second re-
port of autosomal dominant NDI due to AQP2 gene
mutations.
Subjects and Methods
Subjects
Three Japanese families with NDI were investigated.
The pedigrees of these families are depicted in figure 1.
Clinical pictures of the two members (III-3 and IV-5) of
family A were reported 17 years ago (Ohzeki et al.
1984). In brief, a 17-mo-old male patient (IV-5) was
admitted to a university hospital because of recurrence
of polyuria and polydipsia, which had first been noticed
1 year after birth. A water deprivation test for 5 h (caus-
ing a 6.4% body-weight reduction) decreased urine vol-
ume from 140 to 35 ml/hr and increased urine osmolality
from 91 to 333 milliosmoles (mOsm)/kg H2O. The
mother (III-3) of the patient was also examined, since
she had had polyuria and polydipsia from childhood.
Her blood chemistry data were normal, but a large vol-
ume (10.6 L/day) and low osmolality (127 mOsm/kg
H2O) of urine were noticed. Urine volume decreased
from 460 to 250 ml/hr, and urine osmolality increased
from 139 to 264 mOsm/kg H2O, after 5-h water dep-
rivation, which caused a 4.0% body-weight reduction.
Furthermore, these two patients were measured for uri-
nary cAMP excretion, after nasal administration of 1-
deamino-8-D-arginine vasopressin (DDAVP). Urine vol-
ume and osmolality did not appreciably respond to
DDAVP, but cAMP excretion increased 6- and 20-fold
in the son and mother, respectively. Type II NDI (in
which defects are located distal to cAMP generation)
was diagnosed in these two patients. The individuals
shaded in black or gray in the expanded family tree
shown in figure 1A were known to have polyuria and
polydipsia. This pedigree figure clearly indicates an au-
tosomal dominant inheritance of the disease.
The female patient (II-2) of family B was born to un-
related parents; both the pregnancy and the delivery
were uneventful. Polyuria and polydipsia were not rec-
ognized until age 3 years, when she was referred to a
university hospital because of dehydration with growth
and mental retardation. Her urine osmolality remained
low (120 mOsm/kg H2O), despite the presence of severe
hyperosmotic dehydration (serum Na 169 milliequiv-
alents/liter; urea nitrogen 36 mg/dl; creatinine 1.3 mg/
dl) and a markedly elevated plasma AVP level (18.8 pg/
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ml). Polyuria (4–5 liters/m2) became apparent after
hydration, and it was not improved by nasal DDAVP
administration. None of her family members had poly-
uria or polydipsia.
The patient in family C (III-2) was born without com-
plications. At age 5 mo, he was noticed to have frequent
vomiting, and subsequent examination indicated the
presence of hydronephrosis of the left kidney. After age
16 mo, he was recognized to have polyuria (13 liters/
day) and polydipsia. At age 28 mo, he was admitted to
a university hospital for clinical evaluation. No abnor-
malities were found except polyuria. A water depriva-
tion test showed low urine osmolality (177 mOsm/kg
H2O), despite a high blood AVP level (11.4 pg/ml) in
the normal water-drinking condition, and urine osmo-
lality gradually increased to 468 mOsm/kg H2O after 9
h of water deprivation, with a 3.4% body weight re-
duction. The urine osmolality further increased to 551
mOsm/kg H2O after administration of 10 mg of DDAVP.
Partial NDI was diagnosed in this patient. There were
no family members reporting similar symptoms.
Genomic DNA was obtained from the peripheral
blood of the patients. Informed consent was obtained
from all participants.
Construction of Mutants and In Vitro cRNA Synthesis
cDNAs of human AQP2 (GenBank accession num-
ber NM000486) were mutated by the PCR technique,
using wild-type cDNA as a template (Kuwahara et al.
1995; Goji et al. 1998). A fragment between the NcoI
site at nucleotide 135 and the XbaI site in pAQP/ev1
was replaced by a PCR fragment encoding the mutants.
Capped RNA transcripts of wild-type and mutated
AQP2 were synthesized in vitro with T3 RNA poly-
merase, using XbaI-digested cDNA.
Measurement of Osmotic Water Permeability of
Oocytes
Oocytes at stage V–VI were obtained from Xenopus
laevis. Each oocyte was injected with 40 nl of water (as
a control) or with 5 ng or 0.3 ng of either the wild-type
or mutant AQP2 cRNAs. After incubation for 48 h at
20C in Barth’s buffer, osmotic water permeability (Pf)
of the oocytes was measured at 20C from the time of
osmotic cell swelling (Kuwahara et al. 1995; Goji et al.
1998).
Immunoblot Analysis
Lysates and plasma-membrane fractions of oocytes
were obtained as described elsewhere (Wall and Patel
1989; Kuwahara et al. 1999). After being heated at 70C
for 10 min, samples were separated by SDS-PAGE. Oo-
cyte lysates from the equivalent of one-fifth of an oocyte,
or plasma membranes from 20 oocytes, were applied in
each lane. The samples were transferred to Immobilon-
P filters (Millipore), using a semi-dry system. The filters
were incubated for 1 h with an affinity-purified antibody
against 15 C-terminal amino acids of the wild-type or
mutant AQP2. Because the amino acid sequence of the
C-terminal end was common among the three AQP2
mutants, as shown in figure 3, one antibody against this
portion (ASAVSRRGGGCRREP) was generated to de-
tect these mutants. The filters were further incubated for
1 h with 125I-protein A solution, and autoradiography
was performed.
For native PAGE, a nondissociative detergent, per-
fluorooctanoic acid (PFO) (Wako Pure Chemical Indus-
tries) was used. PFO has been shown to be particularly
effective in the solubilization of intractable membrane
proteins, such as the membrane-spanning V0 subunit of
the V-type ATPase, the cystic fibrosis transmembrane
regulator, the band 3 protein, and the Kir 2.1 K channel
(Shepherd and Holzenburg 1995; Ramjeesingh et al.
1997, 1999). PFO-PAGE was performed as described
in detail elsewhere (Shepherd and Holzenburg 1995;
Ramjeesingh et al. 1997, 1999). Membrane fractions of
90–100 oocytes were dissolved in 500 ml of a solubili-
zation buffer (50 mM Tris base, 1 mM dithiothreitol, 5
mM EDTA, 4% [w/v] PFO, 10% [v/v] glycerol, 1 mM
phenylmethylsulfonyl fluoride (PMSF), and 5mg of leu-
peptin and pepstatin; the pH was adjusted to 8.0 with
NaOH). After a 12-h incubation at 4C, the samples
were concentrated to 50 ml through use of centrifugal
filter devices (Microcon YM-10, Millipore). In one pro-
tocol, the samples were further incubated with 4 M urea
for 30 min at room temperature. The running buffer
contained 25 mM Tris, 192 mM glycine, and 0.5% (w/
v) PFO, and the pH was adjusted to 8.5 with NaOH.
The samples were separated by PFO-PAGE on precast
12.5% Tris/glycine gel without SDS (Multi Gel, Daiichi
Pure Chemicals), in an ice-cold running buffer, followed
by immunoblot analysis.
Immunocytochemistry
Oocytes were fixed in 4% paraformaldehyde for 4 h
and were cryoprotected overnight in phosphate-buffered
saline (PBS) containing 30% sucrose (Kuwahara et al.
1999). The samples were embedded in OCT compound
(Tissue-Tek) and were frozen in liquid nitrogen. Cryostat
sections were incubated for 30 min in PBS containing
1% BSA. After three washes in PBS, the sections were
incubated for 60 min with an antibody against the wild-
type or mutant AQP2 diluted at 1:500, rinsed with PBS,
and further incubated for 30 min with fluorescein-5-
isothiocyanate (FITC)–labeled goat anti-rabbit IgG (1:
200, Sigma). The oocytes were imaged with a fluorescent
confocal microscope at 400# magnification (Carl Zeiss
LSM 510).
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Figure 2 DNA sequencing of the mutated regions of the AQP2
gene found in three families with NDI.
Immunoprecipitation
Membrane fractions of 60–70 oocytes were prepared
as described elsewhere (Preston et al. 1993). Each sample
was dissolved in 250 ml of a solubilization buffer (20
mM Hepes [pH 7.4], 1 mM dithiothreitol, 1 mM EDTA,
5 mM ethyleneglycoltetracetic acid, 5 mM b-glycero-
phosphate, 0.5% [v/v] NP-40, 0.5 [v/v] deoxycholate, 1
mM PMSF, and 5mg/ml of leupeptin and pepstatin).
Twenty microliters of an antibody-bound protein G-aga-
rose (Protein G PLUS-Agarose, Oncogene Science) was
added to each sample and incubated for 12 h at 4C.
The samples were washed three times, were dissolved in
30 ml of Laemmli buffer, and were analyzed by SDS-
PAGE (Laemmli 1970). Fifteen microliters of sample was
applied in each lane. The samples that were immuno-
precipitated with an antibody against the wild-type or
mutant AQP2 were detected by both antibodies.
Preparation and Pf Measurement of Yeast Vesicles
The wild-type and mutant AQP2s were expressed in
a protease-deficient BJ3505 strain of Saccharomyces
cerevisiae yeast cells, as described elsewhere (Kuwahara
et al. 1999; Shinbo et al. 1999). The Pf of the yeast
vesicles was measured by a light-scattering method, us-
ing an SX-18MV stopped-flow apparatus (Applied
Photophysics Ltd.).
Results
Direct sequencing of DNA strands from the patients in
these three families detected no mutations in the AVPR2
gene but found three different mutations (one mutation
for each family) in a single allele in exon 4 of the AQP2
gene. The mutations were confirmed by sequencing of
subcloned PCR-amplified DNA fragments of the patients
(fig. 2). In family A, a deletion of one of two Gs at
nucleotides 720 and 721 (721delG) was found, and this
mutation cosegregated with clinical symptoms of NDI
(fig. 1). A 10-bp deletion starting at 763 (763–772del),
as well as a deletion of 7 bp starting at 812 and encom-
passing the stop codon (812–818del), were found in
families B and C, respectively (fig. 2). The mutations in
families B and C were not observed in other members
of the families (fig. 1), indicating that these were de novo
mutations. Interestingly, all three mutations were found
in the C-terminus of AQP2 (fig. 3A). The 3′-most distal
mutation found in exon 4, 812–818del (family C),
causes a frameshift, and a new stop codon is created
180 nucleotides downstream (fig. 3B). As a result, this
mutant AQP2 protein consists of a wild-type AQP2 lack-
ing the last amino acid (alanine 271) and having a new
polypeptide of 61 amino acids (fig. 3C). The other mu-
tations, 763–772del and 721delG, also cause frameshifts
that result in the addition of 76 and 93 amino acids,
respectively (fig. 3C). These three mutant AQPs consist
of 330–333 amino acids and share the most terminal 61
amino acids, as shown in figure 3B. Because the mu-
tations were found only in one allele, NDI was consid-
ered to follow an autosomal dominant pattern in these
patients; the results for family A are consistent with this
inheritance pattern (fig. 1).
In oocytes injected with water (controls) or with
5 ng of cRNA encoding the wild-type or mutant
AQP2, Pf values ( standard error [SE]; in cm/s)410
were 12  1 (control), 179  12 (wild type), 27  3
(721delG), 25  2 (763–772del), and 30  2 (812–
818del) (fig. 4A). The relative Pf value for wild-type
AQP2 versus the control was 14.9, whereas those for
the mutants were 2.1–2.5. To see whether these mutants
show a “dominant-negative effect,” 5 ng of one of the
mutant cRNAs was coinjected with 5 ng of the wild-
type cRNA. Pf was lowered by 39%–46% but was still
8.1–9.0 times higher than that of the control. Pf was
also measured in oocytes injected with 0.3 ng of cRNA
(fig. 4B). The wild-type AQP2 increased Pf 6.0-fold,
whereas the mutant AQP2s elevated Pf only 1.3–1.8-
fold. A large reduction of Pf (58%–65%) was observed
upon coinjection of one of the mutant cRNAs with the
wild-type cRNA, which provided support for a domi-
nant-negative effect. All of these three mutants lack the
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Figure 3 Sequence and structure of the wild-type (WT) and mu-
tant AQP2 cDNAs. Nucleotide and amino acid residue numbers cor-
respond to the cDNA; the A of the initiator Met codon is nucleotide
1. A, Nucleotide and amino acid sequence at the C-terminal site of
wild-type AQP2. The boxed bases are the deleted bases detected in
patients with NDI who are included in the present study. One, ten,
and seven nucleotides were deleted, starting at 721 (721delG), 763
(763–772del), and 812 (812–818del), respectively. B, Sequences of the
C-terminus in 812–818del. This mutation shifted the stop codon 180
nucleotides downstream, resulting in an addition of 61 new amino
acids (underlined) to the terminal end. C, Schematic structure of mu-
tant AQP2s. The frameshift mutations 721delG, 763–772del, and
812–818del result in the addition of 93, 76 and 61 new amino acids,
respectively. Because the number of deleted bases were 3# n 1
( , 2, or 3), 61 C-terminal amino acids are common in these threenp 0
mutants. All of the three AQP2 mutants lack the last amino acid of
the wild-type AQP2 (alanine at codon 271).
Figure 4 Pf of oocytes expressing wild-type and mutant AQP2s.
Oocytes were injected with 40 nl of water (control), or cRNA of the
wild-type (WT) or one of the mutant AQP2s (721delG, 763–772del,
812–818del, and A271del). Either 5 ng (A) or 0.3 ng (B) of cRNA
was injected. For coexpression, one of the mutated cRNAs was coin-
jected with the wild-type cRNA. Pf was calculated from the time of
osmotic cell swelling of the oocytes. Each bar represents the meanSE
of 21–24 measurements.
alanine at position 271 that is present in the wild-type
AQP2. The mutant lacking A271 (A271del) was con-
structed to evaluate a possible role of this residue. The
Pf of A271del was comparable to that of the wild type,
suggesting that the loss of A271 was not responsible for
the decreases of Pf in the mutants.
The expression of the wild-type and mutant AQP2
proteins were examined by immunoblotting of the ly-
sates and plasma-membrane fractions of the oocytes in-
jected with 5 ng of cRNA. An antibody against the wild-
type AQP2 identified a 29-kD band in both the lysates
and plasma membranes of oocytes expressing the wild-
type or A271del mutant AQP2 (A271), but no bands
in oocytes injected with cRNA of 721delG, 763–772del,
or 812–818del mutant AQP2 (fig. 5A). This would be
due to reconstruction of the C-terminus of AQP2, which
is the site that the antibody recognizes. An antibody
against the mutant AQP2 detected bands at 34 kD in
the lysates of mutant-protein–expressing oocytes but
not in the plasma membranes (fig. 5B), suggesting that
the mutant AQP2 proteins were synthesized but not
translocated to the cell surface. In oocytes coinjected
with cRNA of one of the mutant AQP2s and wild-type
AQP2, the mixture of the two antibodies recognized
both 29-kD and 34-kD bands in the lysates, at similar
expression levels (fig. 5C). Comparison of 29-kD bands
suggested that the coinjection slightly decreased the ex-
pression of the wild-type AQP2 proteins. In the plasma
membranes, only 29-kD bands were seen, and the band
intensity of the coinjected oocytes was weaker than that
of the wild-type oocytes, suggesting that the coexpres-
sion of the AQP2 mutants attenuated the cell-surface
expression of the wild-type AQP2.
Next, immunocytochemistry was performed to fur-
ther determine the expression of the wild-type and mu-
tant AQP2s. The plasma membrane of water-injected
oocytes was not stained with an anti–wild-type AQP2
Kuwahara et al.: Autosomal Dominant NDI 743
Figure 5 Immunoblot of the oocyte lysates and plasma-membrane fractions probed with an affinity-purified antibody (Ab) against wild-
type or mutant AQP2. Oocytes were injected with water (C) or with 5 ng cRNA of wild-type (WT) or mutant AQP2s (“721” denoes 721delG;
“763” denotes 763–772del; “812” denotes 812–818del; and “A271” denotes A271del). The lysates from the equivalent of one-fifth of an
oocyte (upper panels) or the membranes from the equivalent of 20 oocytes (lower panels) were loaded in each lane. The protein expression
was detected with an anti–wild-type-AQP2 antibody (A), an anti–mutant AQP2 antibody (B), or a mixture of both (C).
antibody (fig. 6A), whereas a bright surface staining was
observed in oocytes expressing the wild-type AQP2 (fig.
6B). Immunofluorescence of the plasma membranes
stained with anti–mutant AQP2 antibody was trivial in
oocytes injected with 5 ng of cRNA of either 721delG,
763–772del, or 812–818del (fig. 6C–E). In oocytes
coinjected with 5 ng each of the wild-type and 721delG
cRNA, a clear membrane labeling was visible with an
anti–wild-type AQP2 antibody (fig. 6F) but not with an
anti–mutant AQP2 antibody (fig. 6G). These results
suggested that the surface expression of the wild-type
AQP2 is responsible for the significant Pf of the oocytes
coinjected with the wild-type and mutant cRNAs, as
shown in figure 4A. An anti–wild-type AQP2 antibody
detected a sharp staining in oocytes injected with 0.3
ng cRNA of the wild-type AQP2 (fig. 6H) but did not
show the surface staining in oocytes coinjected with 0.3
ng each of the mutant cRNAs (fig. 6I–K).
Dominant-negative effects of these mutants may be
due to the oligomerization of the wild-type and mutated
AQP2 proteins. To examine whether the wild-type and
mutant AQP2s form oligomers, immunoprecipitation
was performed with the oocyte membrane fractions in-
jected with cRNA of the wild-type AQP2, 721delG, or
both. When immunoprecipitated with the anti–wild-
type AQP2 antibody, the same antibody identified a 29-
kD band in the samples of the wild-type and coinjected
oocytes (fig. 7A, upper panel). In the same samples, a
34-kD band was detected by the antibody against the
mutant AQP2 (fig. 7A, lower panel), suggesting that the
wild-type AQP2 and 721delG mutants form mixed oli-
gomers. In the samples immunoprecipitated by the an-
tibody against the mutant AQP2, an anti–wild-type
AQP2 antibody recognized a 29-kD band (fig. 7B, upper
panel), again suggesting the formation of mixed oli-
gomers. Similar results of oligomerization were seen in
oocytes coinjected with cRNA of the wild-type AQP2
and either the 763–772del or 812–818del mutant (data
not shown). It has been demonstrated that the wild-type
AQP2 exists as tetramers (Jung et al. 1994; Kamsteeg
et al. 1999). To analyze oligomeric states of the wild-
type and mutant AQP2s, the oocyte membrane samples
were separated by PFO-PAGE. The wild-type AQP2 and
721delG migrated as bands with apparent molecular
masses of 112 kD (fig. 7C, lane 1) and 126 kD (fig. 7C,
lane 2), respectively—findings consistent with tetra-
merization of both the wild-type and mutant AQP2 pro-
teins. When the same sample of 721delG was further
incubated with 4 M urea before loading, a clear band
and a faint band were detected at 34 kD and 65 kD,
respectively (fig. 7C, lane 3). These apparent molecular
masses corresponded to those of the monomer and di-
mer of the mutant AQP2, suggesting that the treatment
with 4 M urea led to the dissociation of the tetramer
of the mutant AQP2. Similar results of native PAGE
were obtained in oocytes expressing 763–772del or
812–818del (data not shown).
The oocytes injected with 5 ng of mutant cRNA
showed faint expression of the mutants in the plasma
membrane and some water permeability (figs. 4 and 6),
suggesting that these mutants may be functional water
channels. Since the yeast expression system is free from
trafficking problems (Shinbo et al. 1999), we expressed
the wild-type and mutant AQP2s in yeast cells and mea-
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Figure 6 Immunocytochemistry of oocytes injected with cRNA encoding the wild-type or mutant AQP2s. Oocyte sections were incubated
with an affinity-purified antibody against the wild-type or mutant AQP2 and immunostained with goat anti-rabbit IgG conjugated with FITC.
The sections were viewed with a confocal microscope at 400# magnification. A and B, Water-injected oocyte (A) and oocyte injected with 5
ng of the wild-type cRNA (B), probed with an anti–wild-type AQP2 antibody. C–E, Oocyte injected with 5 ng cRNA of 721delG (C), 763–772del
(D), or 812–818del (E), detected with an anti–mutant AQP2 antibody. F–G, Oocyte coinjected with 5 ng each of cRNA of the wild-type and
721delG mutant incubated with an anti–wild-type AQP2 antibody (F) or an anti–mutant AQP2 antibody (G). H–K, Oocyte injected with 0.3
ng cRNA of the wild-type (H) or coinjected with 0.3 ng each of cRNA of the wild-type and one of 721delG (I), 763–772del (J), or 812–818del
(K), incubated with an antibody against the wild-type AQP2.
sured their Pf. The rate of initial volume decrease pro-
vides a quantitative measure of Pf. Pf values of the wild-
type AQP2 vesicle ( cm/s, ) were4338 40# 10 np 7
8.7 times higher than those of the control ( ,39 8
). The Pf of 721delG ( , ) and ofnp 8 273 22 np 7
812–818del ( , ) were as high as that of298 36 np 6
wild-type AQP2, suggesting that water channel function
is maintained in these AQP2 mutants. These results may
be explained by the fact that the water-transporting pore
of AQP monomers is dependent on the six transmem-
brane spanning domains and five connecting loops that
are identical in these mutants (Jung et al. 1994; Cheng
et al. 1997; Walz et al. 1997; Murata et al. 2000).
Our results presented in figures 5 and 6 suggest an
impaired intracellular trafficking of the AQP2 mutants.
One possible mechanism for this effect may be that the
common C-terminal tail of the AQP2 mutants (the last
61 amino acids; see fig. 3) may bind with other intra-
cellular proteins, thereby hindering the trafficking of the
AQP2 mutants. If this is the case, the following scenario
would be possible: if the C-terminal polypeptide is coex-
pressed with the AQP2 mutants, the polypeptide would
combine with the putative binding proteins, which, in
turn, would stimulate the plasma membrane expression
of the mutant AQP2 and increase Pf. To examine this
possibility, cRNAs encoding the C-terminal portion and
a mutant AQP2 (721delG) were coinjected into oocytes.
The coexpression did not affect the oocyte Pf of the
721delG AQP2 (fig. 8A). In coinjected oocytes, the im-
munoblot of the lysates detected independent expression
of two proteins, at 34 kD and 7 kD, that correspond
to the 721delG mutant and the C-terminal peptide, re-
spectively (fig. 8B), but these bands were absent in the
immunoblot of plasma membranes (fig. 8C). Thus, the
expression of the C-terminal peptide did not show a
rescue effect.
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Figure 7 Oligomeric states of the wild-type and mutant AQP2 proteins. A, Immunoprecipitation of oocyte membrane fractions injected
with water (C) or cRNA of the wild-type AQP2 (WT), 721delG (721), or both (WT  721). Samples were immunoprecipitated with a wild-
type AQP2 antibody (Ab) and were immunoblotted with the same antibody (upper panel) or with an antibody against mutant AQP2 (lower
panel). B, Samples were immunoprecipitated with an antibody to the mutant AQP2 and were immunoblotted with an antibody to the wild-
type AQP2 (upper panel) or the mutant AQP2 (lower panel). C, Determination of the oligomeric structure by PFO-PAGE. Membrane samples
from 90–100 oocytes expressing the wild-type AQP2 and 721delG mutant were applied in each lane. Lane 1, Wild-type AQP2; lane 2, 721delG;
lane 3, 721delG treated with urea. The sample of 721delG was further incubated with 4 M urea for 30 min at room temperature before loading.
Discussion
NDI in the three families in the present study is consistent
with an autosomal dominant trait. Several clear differ-
ences exist between clinical characteristics of our patients
and those of patients with autosomal recessive NDI
caused by AQP2 mutations or with X-linked NDI caused
by AVPR2 mutations (Arthus et al. 2000; Morello and
Bichet 2001). Polyuria and polydipsia, the most promi-
nent symptoms in patients with typical NDI, were not
evident immediately after birth, and they appeared after
some time lag in our patients (after age 1 year). This is
in sharp contrast to an immediate onset of these symp-
toms in patients with autosomal recessive or X-linked
recessive NDI. Furthermore, urine-concentrating ability
was conserved to some extent in our patients; water dep-
rivation could increase urine osmolality to above or near
plasma osmolality, which, again, is different from that
found in patients with recessive or X-linked NDI, in
whom urine osmolality hardly exceeds 200 mOsm/kg
H2O. This residual urine-concentrating ability might pre-
vent a clear awareness of polyuric symptoms in our pa-
tients in infancy, when milk feeding causes natural mild
polyuria. Mulders et al. (1998) recently reported a family
with NDI showing dominant inheritance. The mutation
in that case was an AQP2 missense mutation (E258K)
located in the C-terminus. Although the type of mutation
is different from that in our cases, the clinical features of
the patients appear similar. Their female patient and her
daughter with E258K could increase urine osmolality to
350 mOsm/kg in response to dDAVP infusion. The daugh-
ter progressively showed increased polyuric-polydipsic
symptoms with age. Taken together, milder clinical pre-
sentation of NDI symptoms appear to be a common fea-
ture of dominantly inherited NDI.
Oocyte Pf increased 15-fold after expression of 5 ng
cRNA encoding the wild-type AQP2 (fig. 4A). The wild-
type AQP2 was abundantly expressed in the oocyte
plasma membrane (figs. 5A and 6B), and immunoblot
and immunoprecipitation analysis suggested the for-
mation of tetramers (fig. 7C), findings that are consis-
tent with previous reports (Jung et al. 1994; Kamsteeg
et al. 1999). On the other hand, expression of 5 ng
cRNA of either 721delG, 763–772del, or 812–818del
mutant AQP2 increased Pf (2.1–2.5-fold) much less
than did that of wild-type AQP2 (fig. 4A). The mutant
proteins were expressed weakly in the plasma mem-
brane (figs. 6C–6E), despite preserved intracellular syn-
thesis (fig. 5B) and tetramerization (fig. 7C). Thus, im-
paired trafficking to the cell surface membrane is likely
the primary defect of these mutant AQP2 proteins. In
general, membrane proteins are synthesized on ribo-
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Figure 8 Coexpression of the C-terminal portion of the mutant AQP2 protein with mutant AQP2 protein in oocytes. Five nanograms of
cRNAs encoding the portion of the last 61 amino acids (C-terminus), the mutant AQP2 721delG (721), or both, were injected into oocytes.
A, Oocyte Pf. Each bar represents the mean SE of 17–20 measurements. B and C, Immunoblot of the oocyte lysates (B) and plasma-membrane
fractions (C), probed with an antibody against the mutant AQP2.
somes and enter the endoplasmic reticulum (ER). After
folding and oligomerization in the ER, proteins are
transported to the Golgi apparatus (Amara et al. 1992;
Halban and Irminger 1994). However, the oligomeri-
zation is suggested to take place after leaving the ER in
several proteins, such as dipeptidylpeptidase IV (Jascur
et al. 1991), connexin43 (Musil and Goodenough
1993), and AQP2 (Kamsteeg 1999). For the E258K mu-
tation, Kamsteeg et al. (1999) reported that the mutated
AQP2 proteins were retained in the Golgi apparatus
and were inhibited from further translocation to the
plasma membrane; our mutant proteins might be mis-
handled similarly.
Immunoprecipitation and subsequent immunoblot
studies demonstrated the ability of the mutated AQP2s
to form tetramers with wild-type AQP2 (fig. 7). The
dominant-negative effect of the mutants can be ex-
plained by this ability. Only tetramers made of wild-
type AQP2 can be translocated to the cell surface,
whereas those containing at least one AQP2 mutant
may be retained inside the cell. Interestingly, a domi-
nant-negative effect was clearly shown when 0.3 ng
cRNA was expressed in the oocytes, but it was not
apparent when 5 ng was expressed. A similar result was
reported for the E258K mutant (Mulders et al. 1998).
This may be explained as follows: synthesis and surface
expression of wild-type AQP2 are efficient and well sat-
urated with 5 ng cRNA expression. A dominant-neg-
ative effect may not be apparent in this condition but
would become clear when the amount of AQP2 ex-
pression is reduced (to 0.3 ng).
Several cellular mechanisms are possible for the re-
tarded trafficking of the three AQP2 mutants found in
the present study. One possibility is that the sequence
deleted by the mutations might be critical for normal
translocation of AQP2. Alanine at 271 (the last amino
acid) was the only residue commonly eliminated in these
mutations (fig. 3). However, the A271del mutant had a
Pf similar to that of the wild type (fig. 4) and was well
expressed in the plasma membrane (fig. 5A), suggesting
that deletion of A271 is not involved in the misrout-
ing of the mutants. The 721delG, 763–772del, and
812–818del mutations resulted in addition of new 93–,
76–, and 61–amino acid residues, respectively, and 61
residues at the C-terminal tail were shared among these
mutants (fig. 3). Therefore, it is very likely that this C-
terminal tail causes a trafficking defect of the AQP2
mutants. How can this be possible? It is unlikely that
these new C-terminal tails bind to other cellular proteins
(for example, cytoskeletons), thereby inhibiting trans-
location of the mutant AQP2s, because coexpression of
the new C-terminal polypeptide did not increase the Pf
or surface expression of the AQP2 mutant (fig. 8). It
may be that the addition of new amino acids to the C-
terminus of AQP2 inhibits normal trafficking. The new
C-terminal tail may cause a conformational change of
the whole C-terminus and inhibit binding of vesicle traf-
ficking–related targeting proteins, such as VAMP2
(Nielsen et al. 1995b), syntaxin-4 (Mandon et al. 1996),
and dynein/dynactin (Marples et al. 1998), which have
been shown to colocalize with AQP2 in the collecting-
duct cells. This speculation is consistent with the lo-
cation of the E258K mutation in the C-terminus. This
missense mutation may also elicit a conformational
change in the C-terminus. Thus, mutations identified in
patients with autosomal dominant NDI underscore the
importance of the C-terminus of AQP2, in its trafficking
to the cell surface.
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